Modus Therapeutics Holding AB
Entity

  • Modus Therapeutics Holding AB

    Created in 2011
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    469

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Olof Palmes gata 29, 111 22 Stockholm, Sweden

    Stockholm

    Sweden

  • Employees

    Scale: 2-10

    Estimated: 4

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year, 7 months ago
Description
  • Value proposition

    We develop sevuparin to help patients with severe conditions and high unmet medical need.

    Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.

    Sepsis, Systemic inflammation, Heparinoids, Pharmaceutical development, and Pharmaceutical research

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics